Pharmacodynamic Properties of Subcutaneous Immunoglobulin in Myasthenia Gravis: Sub-analyses From an Open-Label Trial

por Putko, Brendan N., Beecher, Grayson, Siddiqi, Zaeem A.
Publicado 2020

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure

por Patel, Vaibhav B., Putko, Brendan, Wang, Zuocheng, Zhong, Jiu-Chang, Oudit, Gavin Y.
Publicado 2012

Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fractio...

por Putko, Brendan N., Wang, Zuocheng, Lo, Jennifer, Anderson, Todd, Becher, Harald, Dyck, Jason R. B., Kassiri, Zamaneh, Oudit, Gavin Y.
Publicado 2014

Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction

por Yogasundaram, Haran, Nikhanj, Anish, Putko, Brendan N., Boutin, Michel, Jain‐Ghai, Shailly, Khan, Aneal, Auray‐Blais, Christiane, West, Michael L., Oudit, Gavin Y.
Publicado 2018